Skip to main content
OpenTrials

Clinical trial condition

Mastocytosis, Systemic

Explore clinical trials studying Mastocytosis, Systemic. Study availability and eligibility vary by location and protocol.

39 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Mastocytosis, Systemic trial results

Active, not recruiting

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

NCT05186753

Conditions
BMM, Bone Marrow Mastocytosis, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • One of a Kind Clinical Research Center Scottsdale, Arizona, United States
  • Modena Allergy and Asthma Clinical La Jolla, California, United States
View all 57 locations
View Trial Details
Active, not recruiting

(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis

NCT03731260

Conditions
Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
View all 49 locations
View Trial Details
Completed

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

NCT03580655

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

NCT03401060

Conditions
Bone Diseases, Bone Diseases, Metabolic, Immune System Diseases, +12 more
Locations
  • Jean Minjoz Hospital, Dermatology department Besançon, France
  • Caen Hospital, Clinical haematology department Caen, France
  • Estaing Hospital, Cellular therapy and clinical haematology department Clermont-Ferrand, France
  • Lille CHRU Hospital, Internal medicine and clinical immunology department Lille, France
View Trial Details
Completed

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

NCT02571036

Conditions
Advanced Cancers, Advanced Systemic Mastocytosis, Bronchial Neoplasms, +53 more
Locations
  • Honor Health (GIST, mastocytosis, other solid tumors) Scottsdale, Arizona, United States
  • UCLA Hematology Center (mastocytosis) Los Angeles, California, United States
  • UCLA (glial malignancies only) Los Angeles, California, United States
  • Stanford University Comprehensive Cancer Center (GIST) Palo Alto, California, United States
View all 26 locations
View Trial Details

Related conditions